Similar Posts
University of Wisconsin Opens Country’s First Master’s in Psychedelic Medicine
The University of Wisconsin is the first in the U.S. to offer a master’s degree in development of psychedelic medicine.
The Millennium’s Primer Series: Neuroinflammation as a Barrier to the Success of Psychedelic-Assisted Therapies
Initial clinical trials into this exciting frontier have unveiled promising outcomes, showcasing remarkable improvements in clinical results using anti-inflammatory, nanoliposomal products prior to the application of a psychedelic agent.
Highlighting Black Psychedelic Businesses, Collectives, and Groups
While there still remain negative perceptions toward psychedelics, Black people are doing psychedelics. There should be more representation to help Black psychedelic enthusiasts be able to find like-minded communities in this space.
Are Ketamine Infusions Addictive?
It is understandable that people are apprehensive about ketamine use considering its well-known misuse. However, when administered under the direction of a medical professional for depression or other mental health related treatment, ketamine does not seem to be addictive in any way.
Guide to Ibogaine – The Ibogaine Experience, Benefits & Side Effects
This article aims to provide a comprehensive exploration of ibogaine, shedding light on its pharmacological mechanisms, potential therapeutic applications, benefits, risks, and the ethical considerations surrounding its use.
How To Change Your Mind: Episode 1 Review
Michael Pollan’s landmark book is now a streaming miniseries, but is the Netflix psychedelics documentary worth the watch?